As of September 30, 2017, Health Advance Inc carries a market capitalization of 2.99M, placing it among publicly traded companies globally. Its enterprise value stands at 3.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.99M |
| Enterprise Value | 3.09M |
As of September 30, 2017, Health Advance Inc has 126.80M shares outstanding.
| Shares Outstanding | 126.80M |
These figures are as of September 30, 2017.
| PB Ratio | 1.12 |
| P/TBV Ratio | -10.57 |
| P/FCF Ratio | -47.99 |
| P/OCF Ratio | -47.99 |
As of September 30, 2017, Health Advance Inc maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Debt / Equity | 3.69 |
| Debt / EBITDA | -1.14 |
These figures cover the twelve months ended September 30, 2017. Return on assets (ROA) is negative at -6.86, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.
| Return on Assets (ROA) | -6.86 |
| Employee Count | 2.00 |
As of the close on October 22, 2026, Health Advance Inc's stock has declined approximately 25.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| 52-Week Price Change | -25.00% |
Over the twelve months ended September 30, 2017, Health Advance Inc generated - - in revenue and converted that into -101,634.00 in net income, yielding earnings per share of 0.00. EBITDA reached -86,634.00, while operating income came in at -101,634.00.
| Operating Income | -101,634.00 |
| Pretax Income | -101,634.00 |
| Net Income | -101,634.00 |
| EBITDA | -86,634.00 |
| EBIT | -101,634.00 |
As of September 30, 2017, Health Advance Inc holds 100.00 in cash and equivalents against 98,922.00 in total debt, resulting in a net debt position of 98,822.00. Total book value stands at 2.68M, with working capital of -283,018.00 providing operational flexibility.
| Cash & Cash Equivalents | 100.00 |
| Total Debt | 98,922.00 |
| Net Debt | 98,822.00 |
| Equity (Book Value) | 2.68M |
| Book Value Per Share | 0.02 |
| Working Capital | -283,018.00 |
Health Advance Inc produced -29,487.00 in operating cash flow over the twelve months ended September 30, 2017.
| Operating Cash Flow | -29,487.00 |
| Free Cash Flow | -29,487.00 |
These figures cover the twelve months ended September 30, 2017. Free cash flow yield is negative at -2.08: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.32, meaning Health Advance Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -0.32 |
| FCF Yield | -2.08 |
Health Advance Inc's most recent stock split took place on February 15, 2013 with a 1:10 split ratio.
| Last Split Date | 2/15/2013 |
| Split Ratio | 1:10 |
As of September 30, 2017, Health Advance Inc has an Altman Z-Score of -15,089.45, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -15,089.45 |
Already premium?